Structure-Based Drug Design Summit

The Structure-Based Drug Design Summit (February 3-5, 2026, San Diego) brings together structural biologists, medicinal chemists, and computational scientists to advance rational drug design using cutting-edge structural techniques. The conference focuses on integrating multiple structural biology tools including Cryo-EM, X-ray crystallography, NMR, HDX-MS, and AI-driven modeling to visualize protein structures, identify druggable pockets, and optimize candidates across small molecules and biologics. Attendees from companies like Genentech, Gilead, Vertex, and Eli Lilly will share practical strategies for leveraging structural insights to improve selectivity, reduce attrition, and accelerate hit-to-lead optimization while addressing challenging targets and multi-modal drug design workflows.